Table 4.
Rank of fuzzy TOPSIS for competitiveness key factors
| Pharmaceutical industry’s competitiveness key factors | Important level | Distance from positive ideal | Distance from negative ideal | Key factors’ rank |
|---|---|---|---|---|
| Human capital |
0.67 |
0.56 |
1.15 |
1 |
| Macro-level policies |
0.65 |
0.61 |
1.13 |
2 |
| Strategy and operational effectiveness |
0.56 |
0.73 |
0.91 |
3 |
| Supporting and related industries and clusters |
0.54 |
0.76 |
0.91 |
4 |
| Administrative infrastructure |
0.54 |
0.74 |
0.87 |
5 |
| Capacity for innovation |
0.54 |
0.74 |
0.87 |
6 |
| Organizational practices |
0.49 |
0.86 |
0.82 |
7 |
| Capital market infrastructure |
0.48 |
0.89 |
0.82 |
8 |
| Internationalization of firms |
0.42 |
0.95 |
0.70 |
9 |
| Context for strategy and rivalry | 0.27 | 1.17 | 0.43 | 10 |